Back to Screener

CADRE HOLDINGS, INC. (CDRE)

NYSE Small Cap

Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies

$31.65
Market Cap: $1.4B
Data as of Sep 30, 2025 (TTM)

Price History

Feb 9, 2026 — Apr 4, 2026

Investment Snapshot

  • Trading 166% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 4/9 — moderate financial health
  • ROE of 11.3% — below-average profitability
  • Revenue growing at 8% annually

CADRE HOLDINGS, INC. (CDRE) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NYSE , with a market capitalisation of $1.4 billion . Key value metrics: P/E ratio 37.5, P/B ratio 4.26, Piotroski F-Score 4 out of 9 (moderate financial health) .

Value Score

Key Metrics

P/E Ratio
37.51
4.26
EPS
$0.84
Div. Yield
1.2%
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

CADRE HOLDINGS, INC. — Fundamental Analysis Summary

CADRE HOLDINGS, INC. (CDRE) is currently trading 166% above its Graham Number of $11.88, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 37.5x.

On financial health, CDRE shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 11.3% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.97.

StockPik's composite Value Score for CDRE is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

CDRE reports a solid gross margin of 41.1% (sector average: 33.5%) and a modest operating margin of 9.5%.

CDRE shows revenue growing at 8% year-over-year, with earnings growing at 22%.

CDRE pays a modest dividend yield of 1.2%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
CYRX $8.21 4.7 100
CRMD $6.70 3.6 100
CGEN $2.06 5.5 100
ABEO $4.82 4.5 100
BDMD $2.01 5.8 100
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
CDP
Next
CDT